Vaccination against meningococcal disease: Which vaccine to use?

Journal of Travel Medicine

Volumn 9, Issue 3, 2002, Pages 168-169

  Bröker, Michael ^a  

^a Chiron Behring GmbH & Co   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; HUMAN; LETTER; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; VACCINATION;

EID: 0036080189     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.23861     Document Type: Letter

References (7)

1. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec
2. Immunogenicity of bivalent AC polysaccharide meningococcal vaccine in children aged 6 through 24 months
3. Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers
4. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants. A randomized controlled trial
5. Can meningococcal conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharides vaccine?
6. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
7. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England